Match Document Document Title
9034387 Intrinsically fluorescent carbon nanospheres and a process thereof  
The present invention provides solution to the problem involved in delivery of active molecules to nucleus. More particularly, the invention provides intrinsically fluorescent and inherently...
9034380 Nanoparticles comprising antibacterial ligands  
Materials and Methods are disclosed for producing nanoparticles linked to antibacterial ligands, including antibiotics and/or molecules which bind to bacterial markers, and for the use of the...
9012519 Compositions and methods of delivery of pharmacological agents  
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human...
9012518 Compositions and methods of delivery of pharmacological agents  
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human...
8999395 Pharmaceutical compositions for oral administration in the form of stabilised aqueous suspensions  
The invention relates to a liquid pharmaceutical composition, in the form of a suspension of micronized powder of active substance in an acceptable physiological liquid medium, stabilized over...
8999396 Breast cancer therapy based on hormone receptor status with nanoparticles comprising taxane  
The present invention relates to methods and kits for the treatment of breast cancer based on hormone receptor status of progesterone receptor and estrogen receptor comprising the administration...
8993316 Methods and compositions for gene therapy and GHRH therapy  
A composition and method comprising an anti-adjuvant such as DOI (an anti-inflammatory) together with any gene therapy plasmid is disclosed. A method for GHRH production in-vivo using a set of...
8974829 Embolization  
A particle includes a ferromagnetic material, a radiopaque material, and/or an MRI-visible material.
8962030 Nanoparticles for delivery of active agents  
Milled nanoparticles comprising a biologically active agent, at least one biopolymer and a coating containing at least one coating which is a polymer or ligand are produced using milling and...
8962033 Method for improved fibrin sealing  
The present invention relates to a fibrin matrix, its preparation and use for effectively sealing a defect in a mucosa or other moist tissue.
8962025 Rapidly acting dry sealant and methods for use and manufacture  
Compositions, methods, and kits are provided for sealing applications. Compositions are prepared by combining a first cross-linkable component with a second cross-linkable component to form a...
8956656 Production of small particles  
The present invention relates to a method for producing particles of a compound of interest. In a method according to the invention a solution is provided of the compound of interest in a solvent....
8951565 Hemostatic compositions, assemblies, systems, and methods employing particulate hemostatic agents formed from hydrophilic polymer foam such as chitosan  
Improved hemostatic agents take the form of granules or particles that can be used to stanch, seal, or stabilize a site of hemorrhage, including a noncompressible hemorrhage.
8951570 Manufacture of multiple minicapsules  
An extrusion process comprises extruding a material that is flowable when heated and passing the extrudate thus formed through a nozzle 10 to shape the extrudate into a plurality of substantially...
8951571 Polymer vesicles for selective electromagnetic energy-induced delivery  
Provided are polymer vesicles comprising polymersomes, a radiofrequency absorbing moiety, a protein or a polysaccharide associated with the inner leaflet of the membrane and a therapeutic or...
8945602 Porous photonic crystals for drug delivery to the eye  
A minimally invasive controlled drug delivery system for delivering a particular drug or drugs to a particular location of the eye, the system including a porous film template having pores...
8936813 Spray drying methods and related compositions  
A method and apparatus are provided for atomizing a liquid under dispersal conditions suitable for spray drying at a commercial plant scale. In one embodiment, a liquid atomizer has a structural...
8936811 Device coated with glycogen particles comprising nucleic acid complexes  
Embodiments of the invention include particles with nucleic acid complexes, medical devices including the same and related methods. In an embodiment, the invention can include a method of making a...
8932633 Polysaccharide microparticles containing biological agents: their preparation and applications  
A method of preparing polysaccharide glassy microparticles which are less than 10 μum in diameter and contain structurally delicate agents, such as proteins, peptides, gene materials, vaccines,...
8932640 Process for preparing a particle comprising a biological molecule and a carrier polymer  
A process for preparing a particle comprising a biological molecule typically a DNA plasmid, and a carrier polymer, typically poly-lactic acid (PLA), in which an organic solvent solution of the...
8920781 Carrier particles for use in dry powder inhalers  
A powder for use in a dry powder inhaler includes active particles and carrier particles for carrying the active particles. The powder further includes additive material on the surfaces of the...
8916143 Polymer compositions of dihydroxyacetone and uses thereof  
The present disclosure provides injectable synthetic and biodegradable polymeric biomaterials that effectively prevent seroma, a common postoperative complication following ablative and...
8911789 Methods and apparatus for manufacturing plasma based plastics and bioplastics produced therefrom  
Blood-derived plastic articles prepared from compositions including blood and, in some embodiments, at least one crosslinking agent and/or at least one biological response modifier, that can be...
8900638 Solid preparation comprising alogliptin and metformin hydrochloride  
The present invention provides a solid preparation containing compound (I) [compound (I) is as defined in the specification] or a salt thereof, and metformin hydrochloride, which is useful as a...
8900594 Oral recombinant Helicobacter pylori vaccine and preparing method thereof  
The invention relates to a recombinant protein used for immunoprophylaxis of human Helicobacter pylori infection and a degradable slow-releasing microsphere-encapsulated oral vaccine preparation...
8889902 Acetylsalicylic acid salts  
Novel betaine salts of acetylsalicylic acid, namely 4-trimethylammoniobutanoate acetylsalicylic acid addition salt (gamma-butyrobetaine acetylsalicylate), L-carnitine acetylsalicylic acid addition...
8889105 Bacteriophage compositions for treatment of bacterial infections  
A respirable composition for treatment of a bacterial infection includes one or more active bacteriophages in combination with a pharmaceutically acceptable respirable carrier. The composition...
8889189 Dissolution composition for examining drug solubility  
There are described solid compositions or examining drug solubility comprising bile salts and phospholipids, optionally containing buffer components suitable for preparation of intestinal media...
8883220 Compositions of jasmonate compounds  
The disclosure describes nanocarried and/or microcarried jasmonate compounds and their pharmaceutical compositions, as well as use thereof for treating or preventing angiogenesis-related or...
8877252 Polymer-based sustained release device  
This invention relates to compositions for the sustained release of biologically active polypeptides, and methods of forming and using said compositions, for the sustained release of biologically...
8877240 Tablet binding compositions  
Provided are tablet binding compositions for binding cleaning and/or disinfecting formulation components into tablets. The tablet binding compositions are suitable replacements for traditional...
8871276 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents  
The present invention discloses a dried composition comprising β-casein micelles, assemblies and complexes thereof. The dried composition is stable in the dried state as well as upon re-suspension...
8865223 Beta-casein assemblies for mucosal delivery of therapeutic bioactive agents  
Nanoparticulate assemblies of isolated beta-casein, are useful for encapsulation of bioactive therapeutic substances, particularly therapeutic agents with poor bioavailability. These nano-sized...
8865222 Beta-casein assemblies for enrichment of food and beverages and methods of preparation thereof  
The invention relates to a composition for the enrichment of food and/or beverage and to a method of preparing such composition. The composition comprises additive loaded beta-casein micelles...
8858917 Methods for limiting spread of pulmonary infections  
Formulations have been developed for pulmonary delivery to treat or reduce the infectivity of diseases such as vital infections, especially tuberculosis, SARS, influenza and respiratory synticial...
8846771 Compositions and methods of delivery of pharmacological agents  
The present invention relates to a pharmaceutical composition comprising a pharmaceutical agent and a pharmaceutically acceptable carrier, which carrier comprises a protein, for example, human...
8846105 Dry powder fibrin sealant  
The present invention relates to a dry powder fibrin sealant which comprises a mixture of fibrinogen and thrombin for use in surgery, trauma and other wounds or injuries. It further relates to...
8828359 Particulate materials  
Embodiments of the invention relate to particles of active substances, methods for preparing the particles, formulations containing the particles, and metered dose inhalers containing such...
8821943 Methods and compositions for targeted delivery of therapeutic agents  
Compositions and methods for targeted delivery of therapeutic agents, and particularly for mucosal, oral, nasal, or parenteral delivery of therapeutic agents. The compositions comprise carrier...
8815253 Compositions for inducing immune responses  
The invention provides, inter alia, immunogenic compositions that comprise (a) a first antigen, (b) at least first and second adjuvants, wherein the first adjuvant comprises microparticles and...
8802149 Systems and processes for spray drying hydrophobic and hydrophilic components  
Methods for preparing dry powders having hydrophobic and hydrophilic components comprise combining solutions of the components and spray drying them simultaneously in a spray dryer. The...
8791064 Beta-lactoglobulin-polysaccharide nanoparticles for hydrophobic bioactive compounds  
The present invention provides colloidally stable dispersions of nanoparticles comprising beta-lactoglobulin and a polysaccharide which are transparent when diluted in aqueous media. In particular...
8779000 Saccharide free, storage stable thyroid hormone active drug formulations and methods for their production  
Embodiments of the present invention provide pharmaceutical compositions in unit dosage form that comprise a therapeutically effective amount of levothyroxine sodium; an antioxidant in an amount...
8765148 1C31 nanoparticles  
The invention discloses pharmaceutical compositions in liquid form comprising a peptide with the amino acid sequence KLKL5KLK and an oligodeoxynucleotide with the nucleic acid sequence (dIdC)13...
8765666 Adenovirus dodecahedron particles for delivery of pharmaceutical agents  
The embodiment of the invention is a virus-like particle vector, a process for the manufacture thereof, use of the virus-like particle vector and a pharmaceutical composition, which contains the...
8759369 Inhalable solid amorphous particles comprising tiotropium bromide and a co-solid  
An inhalable medicament is provided, in particular a new solid-state form of tiotropium bromide. The medicament can be in the form of solid amorphous particles containing an intimate admixture of...
8753687 Particulate hyaluronic acid/flavonoid suspensions for cellular delivery of bioactive agents  
There is presently provided a suspension of immiscible particles in a solution, wherein the particles comprise an agglomeration of a bioactive agent, for example an anti-cancer agent; and a...
8741645 Test kit comprising a culture instrument with a cell pattern and a gel suitable to embed cell pattern  
The present invention provides a method for performing a biological test under conditions in which an artificially prepared cell pattern with initial position coordinates that can be determined is...
8734853 HDL particles for delivery of nucleic acids  
Disclosed are high density lipoprotein-nucleic acid particles, wherein the particles include (a) an apolipoprotein; (b) a nucleic acid component comprising a therapeutic nucleic acid segment; and...
8735363 Preparation and application of heparin silver  
The present invention relates to a method for preparation of heparin silver, to use of heparin silver in manufacture of medicine for treating burns and/or scalds, to a method of using heparin...